Novo A/S »

Lexeo Therapeutics shares owned by Novo A/S

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Novo A/S

Quarter filed Position value Share count Share price at filing
2024-09-30 $10M 1.1M 9.04
2024-06-30 $23M 1.5M 16.04
2024-03-31 $26M 1.6M 15.68
2023-12-31 $18M 1.3M 13.42

More positions owned by Novo A/S

Vanguard Index Fds Total Stk Mkt (VTI)
Tempus Ai Cl A (TEM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Edgewise Therapeutics (EWTX)
Corcept Therapeutics Incorporated (CORT)
Asml Holding N V N Y Registry Shs (ASML)
salesforce (CRM)
Vaxcyte (PCVX)
Mirum Pharmaceuticals (MIRM)
Miragen Therapeutics (VRDN)
Alibaba Group Hldg Sponsored Ads (BABA)
Insmed Com Par $.01 (INSM)
Crinetics Pharmaceuticals In (CRNX)
Cable One (CABO)
Arrivent Biopharma (AVBP)

View all positions for Novo A/S

Top funds holding Lexeo Therapeutics

Henderson Group
Citadel Advisors
Omega Fund Management
Eventide Asset Management
BlackRock
Frazier Life Sciences Management
Blackstone Group
Novo A/S
Woodline Partners
Vestal Point Capital
BlackRock
Braidwell
Vanguard Group
Siren
Geode Capital Management

View all funds holding Lexeo Therapeutics